NCT02830776View on ClinicalTrials.gov

Topical Bimatoprost for Chemical Blepharoplasty

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

June 30, 2017

Conditions
Dermatochalasis
Interventions
DRUG

bimatoprost 0.03% ophthalmic solution

Latisse (bimatoprost 0.03% ophthalmic solution) applied to the eyelid margin for dermatochalasis (upper eyelid drooping)

Trial Locations (1)

70112

Tulane Department of Dermatology, New Orleans

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Tulane University

OTHER